Helix, a consumer genomics company, today announced the formation of the company’s Scientific Advisory Board (“SAB”) with the appointment of seven of the world’s foremost experts in genomics. The members of the SAB will serve as strategic and scientific resources to Helix as it builds a novel consumer genomics ecosystem. The inaugural SAB includes leaders in population genetics, bioinformatics, medical genetics, and ethics. Robert Green, M.D., MPH of Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School will serve as chair of the Scientific Advisory Board.
“A consumer ecosystem that supports a variety of commercial partners will be in a unique position to assert high standards for scientifically sound products,” said Robert Green, chair of the SAB. “This SAB plans to offer rigorous scientific counsel to Helix, and encourage clear communication from Helix and all of its partners.”
The inaugural members of the Helix Scientific Advisory Board include the University of Michigan’s Goncalo Abecasis.
Goncalo Abecasis, Ph.D., is Felix E. Moore Collegiate Professor of Biostatistics and Chair of the Department of Biostatistics at theUniversity of Michigan. Dr. Abecasis’ research focuses on the development of statistical tools for the identification and study of genetic variants important in human disease.